Androgen blockade based clinical trials landscape in triple negative breast cancer

Yaqin Shi1, Fang Yang1, Doudou Huang1

  • 1Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China.

Insights

Androgen receptor (AR) targeted therapy shows promise for triple-negative breast cancer (TNBC). Combining AR blockade with other treatments may overcome resistance and improve outcomes for TNBC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • Triple-negative breast cancer (TNBC) remains a challenging subtype with limited targeted therapies.
  • Androgen receptor (AR) signaling is increasingly recognized as a potential therapeutic target in TNBC.
  • Understanding AR-associated pathways is crucial for developing effective treatment strategies.

Purpose of the Study:

  • To elucidate the biological interactions of AR signaling in TNBC.
  • To explore combination strategies involving AR-targeted therapy.
  • To identify new avenues for endocrine-based treatment in TNBC.

Main Methods:

  • Preclinical studies investigating AR signaling pathways.
  • Clinical studies evaluating combination therapies.
  • Analysis of AR's interaction with PI3K/AKT/mTOR, cell cycle, and DNA damage repair pathways.

Main Results:

  • AR signaling interacts with key pathways (PI3K/AKT/mTOR, cell cycle, DNA repair) in TNBC.
  • AR signaling influences tumor initiation and immune modulation.
  • Preclinical studies show benefits of androgen-blockade combination therapy.
  • Clinical trials combining AR-targeted therapy with CDK4/6 inhibitors, PI3K inhibitors, chemotherapy, and immunotherapy are ongoing.

Conclusions:

  • AR signaling plays a pivotal role in TNBC pathogenesis.
  • Combination therapies targeting AR and associated pathways offer a promising strategy.
  • Clinical interpretation of AR-related interactions may lead to novel endocrine-based treatments for TNBC.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.1K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
429
Scalar and Vector Triple Products01:06

Scalar and Vector Triple Products

Two vectors can be multiplied using a scalar product or a vector product. The resultant of a scalar product is scalar, while with vector products, the resultant is a vector. These rules of the scalar or vector product between two vectors can be applied to multiple vectors to obtain meaningful combinations. The scalar triple product is the dot product of a vector with the cross product of two vectors.
The scalar triple product is the dot product of a vector with the cross product of two vectors....
4.5K